Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
(
1 selected
)
Type
Guidance (757)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (757)
Apply filters
Showing 741 to 750 of 757
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Vedolizumab for treating moderately to severely active ulcerative colitis
TA342
5 June 2015
5 June 2015
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma
TA269
12 December 2012
1 January 2015
Venetoclax for treating chronic lymphocytic leukaemia
TA796
15 June 2022
15 June 2022
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
TA765
2 February 2022
2 February 2022
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
TA787
27 April 2022
27 April 2022
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
TA663
9 December 2020
9 December 2020
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia
TA561
27 February 2019
27 February 2019
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
TA731
29 September 2021
29 September 2021
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)
TA675
17 February 2021
17 February 2021
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract
TA272
23 January 2013
23 January 2013
Previous page
1
…
73
74
Current page
75
76
Page
75
of
76
Next page
Results per page
10
25
50
All
Back to top